IRHYTHM TECHNOLOGIES INC. news, videos and press releases - Page 5
For more news please use our advanced search feature.
IRHYTHM TECHNOLOGIES INC. - More news...
IRHYTHM TECHNOLOGIES INC. - More news...
- NAMCP Independent Third-Party Review Validates Value Proposition of iRhythm Zio XT Service to Health Systems and Payers
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRhythm Technologies, Inc. - IRTC
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRhythm Technologies, Inc. - IRTC
- INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRhythm Technologies, Inc. - IRTC
- INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Announces Investigation into iRhythm Technologies, Inc. (IRTC)
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRhythm Technologies, Inc. - IRTC
- SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm
- iRhythm Technologies Further Strengthens its Board of Directors with Two New Independent Director Appointments
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of iRhythm Technologies, Inc. - IRTC
- INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against iRhythm Technologies, Inc. and Encourages Investors with Losses to Contact the Firm
- iRhythm Technologies to Present at the William Blair 43rd Annual Growth Stock Conference
- New Data From iRhythm Reinforce the Utility of Long-Term Ambulatory Cardiac Monitoring for Increased Diagnostic Yield and Improved Diagnostic Accuracy of Actionable Arrhythmias
- iRhythm Technologies Announces First Quarter 2023 Financial Results
- iRhythm Technologies to Report First Quarter 2023 Financial Results on May 4, 2023
- iRhythm Technologies Releases 2022 Environmental, Social, and Governance Report Reflecting Strategy to Deliver Purpose-Driven Growth
- Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors
- Four New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC
- iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results
- iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
- iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference
- iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
- Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm’s Product Portfolio Presented at American Heart Association ’22
- New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective
- iRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
- iRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
- iRhythm Technologies Announces Third Quarter 2022 Financial Results
- iRhythm Technologies to Report Third Quarter 2022 Financial Results on November 1, 2022
- iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day
